Cargando…

RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential

Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological func...

Descripción completa

Detalles Bibliográficos
Autores principales: Findeisen, Maria, Rathmann, Daniel, Beck-Sickinger, Annette G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058657/
http://dx.doi.org/10.3390/ph4091248
_version_ 1782321152183500800
author Findeisen, Maria
Rathmann, Daniel
Beck-Sickinger, Annette G.
author_facet Findeisen, Maria
Rathmann, Daniel
Beck-Sickinger, Annette G.
author_sort Findeisen, Maria
collection PubMed
description Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family. Furthermore, we address the biological functions of the ligands and give an overview on their involvement in physiological processes. We provide insights in the knowledge for the design of highly selective ligands for single receptor subtypes to minimize cross-talk and to eliminate effects from interactions within the GPCR system. This will support the drug development of members of the RFamide family.
format Online
Article
Text
id pubmed-4058657
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40586572014-06-16 RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential Findeisen, Maria Rathmann, Daniel Beck-Sickinger, Annette G. Pharmaceuticals (Basel) Review Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family. Furthermore, we address the biological functions of the ligands and give an overview on their involvement in physiological processes. We provide insights in the knowledge for the design of highly selective ligands for single receptor subtypes to minimize cross-talk and to eliminate effects from interactions within the GPCR system. This will support the drug development of members of the RFamide family. MDPI 2011-09-21 /pmc/articles/PMC4058657/ http://dx.doi.org/10.3390/ph4091248 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Findeisen, Maria
Rathmann, Daniel
Beck-Sickinger, Annette G.
RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title_full RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title_fullStr RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title_full_unstemmed RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title_short RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
title_sort rfamide peptides: structure, function, mechanisms and pharmaceutical potential
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058657/
http://dx.doi.org/10.3390/ph4091248
work_keys_str_mv AT findeisenmaria rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential
AT rathmanndaniel rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential
AT becksickingerannetteg rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential